Particle Size Distribution (PSD) Method Validation Using Malvern Mastersizer 3000 for Drug Substance and Drug Product: A Risk-Based Regulatory Lifecycle Approach

Abstract

Particle Size Distribution (PSD) is a critical quality attribute (CQA) for a wide range of pharmaceutical drug substances and drug products, directly influencing dissolution, bioavailability, blend and content uniformity, stability, and manufacturability. Laser diffraction has become the compendial and industrial standard for PSD analysis, with the Malvern Mastersizer 3000 widely used in pharmaceutical development and quality control laboratories. However, regulatory inspections continue to identify deficiencies related to dispersion optimization, method validation, sampling representativeness, and lifecycle management of PSD methods. This study presents a comprehensive evaluation of PSD method validation using both dry and wet dispersion accessories of the Malvern Mastersizer 3000, specifically the Aero S (dry dispersion) and Hydro MV (wet dispersion) systems. Experimental datasets generated during method development and validation were used to evaluate measurement performance for two representative pharmaceutical materials: Drug substance and Drug product. Key PSD parameters, including D10, D50, and D90, were assessed under optimized dispersion conditions. Method validation parameters such as repeatability, intermediate precision, and robustness were evaluated using risk-based analytical validation principles aligned with ICH Q2 (R2). The study is further contextualized within the integrated pharmaceutical quality framework described in ICH Q7-Q11, linking PSD measurement to drug substance characterization, process understanding, and lifecycle management. The findings demonstrate that appropriate dispersion selection and statistically justified validation are essential for ensuring reliable PSD control. Overall, PSD measurement should be viewed not merely as an analytical test but as a critical tool for process understanding and quality control within modern pharmaceutical manufacturing systems. This article reviews the scientific and regulatory basis of laser-diffraction PSD testing and presents a case study validating dry and wet Mastersizer 3000 methods for a drug substance powder and a cream drug product. The study applies dispersion optimization, sampling controls, and precision, intermediate precision, and robustness assessments within an ICH Q2 (R2)-aligned framework. The main conclusion is that material-specific dispersion selection and lifecycle-based validation are necessary for reliable PSD control.